| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1995 | 2015 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 1997 | 2018 | ||||||||
|
tryptophan hydroxylase 1 | 0.553 | 0.731 | 3.2E-07 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 1998 | 2019 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 1998 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.530 | None | 0.800 | 5 | 0 | 1998 | 2005 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 1998 | 2013 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
disease | 0.340 | None | 0.500 | 2 | 0 | 1998 | 2005 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta1 | 0.686 | 0.500 | 0.98 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 1999 | 2006 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.360 | None | 0.200 | 5 | 0 | 1999 | 2004 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1999 | 2014 | ||||||||
|
alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.647 | 0.577 | 1.7E-11 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1999 | 2013 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.560 | None | 0.500 | 4 | 0 | 1999 | 2018 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha6 | 0.678 | 0.423 | 1.3E-12 |
|
disease | 0.340 | None | 0.667 | 3 | 0 | 1999 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1999 | 2017 | ||||||||
|
fatty acid binding protein 2 | 0.608 | 0.654 | 5.0E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
disease | 0.330 | None | 0.800 | 5 | 0 | 2000 | 2012 | ||||||||
|
solute carrier family 1 member 2 | 0.511 | 0.731 | 0.71 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2000 | 2012 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2000 | 2019 |